Healthcare

The GLG Healthcare Practice provides access to a global network of more than 55,000 experts from across the entire healthcare industry including physicians, researchers, scientists, and healthcare industry executives.

The Healthcare Practice provides insight into issues affecting the pharmaceutical, biotechnology, medical device, and healthcare services sectors.

Leading Experts on Healthcare

Leading Experts include Council Members from GLG Member Programs. The Gerson Lehrman Group® (GLG) LeaderSM Program is our premium Member ProgramSM. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Joe Potter

Fake Account
Raw Materials Group
What is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Joe Potter was a Business Development Manager at Potter Global Incorporated, a consulting firm that deals with the healthcare industry. Mr. Potter is knowledgeable in the field of gene splicing. He has experience in solving complex biological problems...

5 news post(s)
William Matsui

Associate Professor
Johns Hopkins University - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

William Matsui, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins School of Medicine in Maryland, since July 2008. Dr. Matsui specializes in clinical and laboratory examination of hematological...

5 news post(s)
Samir Mehta

Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Samir Mehta, MD, is Orthopaedic Surgeon at the Hospital of the University of Pennsylvania. Previously, Dr. Mehta was Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of Pennsylvania....

Jeffrey Bubis, Partner, Hematologist and Medical Oncologist, Cancer Specialists of North FloridaJeffrey Bubis

Partner, Hematologist and Medical Oncologist
Cancer Specialists of North Florida
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Jeffrey A. Bubis, DO, FACOI, FACP, is a Managing Partner, Hematologist and Medical Oncologist at Cancer Specialists of North Florida, the largest private oncology practice in northeast Florida. The group provides comprehensive care to hematology and oncology...

12 news post(s)
John Cochran

Medical Director
Pathology Lab of Georgia
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

John Cochran, MD, is the Founder and Chief Executive Officer of Chestatee Pathology Associates in Atlanta, GA, since 2000. Dr. Cochran is Medical Director of two Atlanta-area hospital laboratories and founded the first independent podiatric pathology...

View All Leading Experts in Healthcare

GLG Study Groups in Healthcare(?)

Study Group Name No. Members
Obstetricians/Gynecologists 2100
Pharmacists (US) 2080
Oncologists (US) 2072
Neurologists 1873
Ophthalmologists 1670

View All Study Groups in Healthcare

GLG Live Meetings in Healthcare(?)

There are no upcoming GLG Live Meetings

View All GLG Live Meetings in Healthcare

GLG Webcasts

Teleconference: Active Pharmaceutical Ingredients Market in India (2:30 PM IST)

6/4/2013

Teleconference: Chronic Myeloid Leukemia Therapies (3:00 PM EDT)

5/23/2013

Teleconference: South African Pharma Industry (11:00 BST (GMT+1))

5/22/2013

Teleconference: DDW Round-up - SBS and IBD Update (10:00 AM EDT)

5/22/2013

Webcast: DNA Prenatal Diagnosis Market in China (4:00 PM HKT/CST GMT+8)

5/14/2013

Play Recording

View All GLG Webcasts & Teleconferences in Healthcare

Engage a member of GLG Healthcare councils

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
9 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software

GLG Clients have access to 65,000+ Healthcare Members Globally:

Healthcare Providers
33,000+
Healthcare Industry Experts
17,000+
Cardiologists
2,500+
Hospital Administrators
1,700+
Pharmacists
1,200+

Become a Council Member

GLG Research StudySM

245 U.S.-based neurologists share their opinion of Tysabri for the treatment of multiple sclerosis.

GLG Research Study: 245 Neurologists on Tysabri for MS

GLG Vital SignsSM

How will Revlimid's use change with this new data? How will Carfilzomib fit into a crowded market?

GLG Vital Signs: American Society of Hematology (ASH) Annual Meeting Recap: Revlimid and Carfilzomib Spotlight


Reactions from ten top medical oncologists, powered by the GLG Healthcare CouncilsSM, regarding data presented by Amgen and Bayer at the 34th European Society of Medical Oncology (ESMO) Congress in Berlin the week of September 21, 2009.

GLG Vital Signs: Post-ESMO Impact: Nexavar/Denosumab

Most Popular Healthcare Insights